Thrive Bioscience, Inc. — Form D
Thrive Bioscience, Inc. of Wakefield, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-07. The offering totals $10.0M, of which $7.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-03-07
- Form: D
- Accession: 0001642601-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $7.2M
- Remaining: $2.9M
- Minimum investment: $8K
- Investors: 36
- Date of first sale: 2016-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281905
Issuer
- Name: Thrive Bioscience, Inc.
- CIK: 0001642601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11 Audubon Road, Wakefield, MA, 01880
- Phone: 9787208046
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Thomas Forest Farb | Director | Wakefield, MA |
| Thomas Forest Farb | Executive Officer | Wakefield, MA |
| Michael Philippe Finney | Director | Wakefield, MA |
| Brock Philippe Reeve | Director | Wakefield, MA |
| Alan Philippe Blanchard | Director | Wakefield, MA |
| Alan Philippe Blanchard | Executive Officer | Wakefield, MA |
| Guy Philippe Broadbent | Director | Wakefield, MA |
| Michael Forest Finney | Director | Beverly, MA |
| Gary Paul Magnant | Director | Beverly, MA |
| Gary Paul Magnant | Executive Officer | Beverly, MA |
Other filings by this issuer (3)
More